New Study Reveals Possible Interaction Between Common Diabetes Drug and Exercise
A recent study has raised questions about the effectiveness of combining a popular diabetes medication with exercise. Researchers at Rutgers University found that adults taking metformin, a common treatment for Type 2 diabetes, experienced fewer health benefits from exercise compared to those who did not take the drug.
In a study published in The Journal of Clinical Endocrinology & Metabolism, the researchers examined how metformin affects blood sugar control and fitness levels. They discovered that individuals who exercised while on metformin showed smaller improvements in blood sugar management, blood vessel function, and aerobic fitness than those who exercised without the medication.
Steven Malin, the study’s lead author and a professor at Rutgers, shared, “Metformin is widely used across the globe to help lower blood sugar. However, it remains uncertain if using it alongside exercise is the most effective approach.”
Malin warned that if metformin minimizes the benefits of exercise, patients might feel tired or notice little improvement in their health, potentially leading to discouragement and a decline in overall well-being.
Currently, about 35 million Americans live with Type 2 diabetes, and many use metformin for both blood sugar regulation and experimental treatments. The study followed 72 adults at risk for metabolic syndrome over 16 weeks. Participants were divided into groups that either took a placebo or 2,000 milligrams of metformin daily while performing different exercise routines.
The results were telling: those who did not take metformin showed significant advancements in their blood vessels’ ability to respond to insulin, which helps deliver oxygen and nutrients to muscles. This benefit was less pronounced in those who were on the medication, as they also experienced reduced improvements in inflammation and blood glucose levels.
Researchers speculate that metformin might disrupt how the body adapts to exercise at a cellular level. Malin pointed out the significance of healthy blood vessels in delivering nutrients, which could explain why muscles struggle to utilize glucose for energy effectively.
While the study assessed a specific group at risk for metabolic syndrome, the researchers caution that their findings may not apply to all diabetes patients. They encourage individuals to continue their medications and exercise but to discuss their treatment plans with healthcare providers.
Future research will further explore how to combine these two approaches effectively and whether adjustments in timing or dosage of metformin could enhance benefits.
Dr. David Cutler, a family medicine physician not involved in the study, noted that the small decline in blood vessel sensitivity should be balanced against the significant results of reduced blood sugar levels from metformin, which can lower the risk of severe complications like heart disease and kidney failure.
Overall, while the findings provide valuable insights, they should not deter those using metformin for Type 2 diabetes treatment but may be more relevant to those using it for other health reasons. For now, metformin remains a primary medication for managing Type 2 diabetes.
